Introduction
============

As the most common sustained arrhythmia diagnosed in the clinic, atrial fibrillation (AF) significantly increases the mortality and morbidity of patients by impairing cardiac function and causing stroke ([@b1-mmr-22-03-1759]). Epidemiological studies have demonstrated that diabetes mellitus (DM) is one of the major risk factors leading to the pathogenesis of AF, which increases the risk by \~40% ([@b2-mmr-22-03-1759]). It was previously reported that autonomic, electrical, electromechanical and structural remodeling, including oxidative stress, connexin remodeling and glycemic fluctuations, triggered by DM, contribute to AF pathophysiology ([@b3-mmr-22-03-1759]). However, the underlying mechanism of the mutual relationship between AF and DM remains mostly unknown, which limits the prevention and treatment of DM-induced AF. Streptozotocin (STZ) is a natural chemical, which can be taken up by pancreatic B cells via the glucose transporter and exert toxic effects. Due to its distinctive effect, STZ is widely applied as a tool to induce experimental DM animal models ([@b4-mmr-22-03-1759]). Hayami *et al* ([@b5-mmr-22-03-1759]) investigated the impact of a DPP-4 inhibitor on AF in a rat model induced by STZ, and found that the administration of STZ greatly increased atrial fibrosis, but sulfonylurea and DPP-4 inhibitors inhibited inflammation and fibrosis of the atria.

Previous research has demonstrated that inflammation and oxidative stress play a critical role in the relationship between DM and AF ([@b6-mmr-22-03-1759]). Therefore, agents mitigating inflammation and oxidative stress might be useful in preventing DM-induced AF. Hydrogen sulfide (H~2~S) has drawn considerable attention, not only due to its inherent activity in human physiology, but also because of its potential as a cardiovascular protector ([@b7-mmr-22-03-1759]). Most studies of H~2~S and cardiovascular disorders have focused on myocardial ischemia/reperfusion injury rather than arrhythmia, especially AF ([@b7-mmr-22-03-1759],[@b8-mmr-22-03-1759]). In addition, there is evidence that downregulated PI3K-Akt-eNOS expression is related to an increased AF inducibility in diabetic rats ([@b9-mmr-22-03-1759]). In addition, it has been noted that H~2~S is associated with inflammation and oxidative-stress responses ([@b10-mmr-22-03-1759],[@b11-mmr-22-03-1759]). In the present study, it was hypothesized that H~2~S could reverse AF and reduce the incidence of AF in diabetic rats via the PI3K-Akt-eNOS signaling pathway, so the effect of H~2~S on DM-induced AF and its underlying mechanisms were explored.

Materials and methods
=====================

### Animal model

A total of 80 adult Sprague-Dawley (SD) rats were used in this study, which was approved by the Experimental Animal Administration Committee of the Second Military Medical University (Shanghai, China). Animal experiments were performed following the Guide for the Care and Use of Laboratory Animals (National Institutes of Health publication 85--23, revised 1996). The 12-week-old male rats (weight 200--220 g) were randomly divided into the control group, the DM group, the H~2~S group, and the DM+H~2~S group (each group included 20 rats). All rats were fed a routine diet and maintained in a standard room environment (18-23°C, humidity 40--60%, 12-h light/dark cycle, and free access to food and water). Animal health and behavior were monitored and evaluated every week, including general condition, appetite, sleep status and survival.

Rats of the DM group and the DM+H~2~S group were administered STZ (60 mg/kg; Wako Chemicals USA, Inc.) dissolved in citrate buffer (Sigma-Aldrich; Merck KGaA) intraperitoneally (i.p.) at the age of 12 weeks. After one week, the rats were tested for fasting blood glucose (FBG) level. The fasting time was 16 h. If the FBG level was \>200 mg/dl, then the rats were selected for the following experiments ([@b5-mmr-22-03-1759]). At the same time, the control group and the H~2~S group were administered citrate buffer only. After the injection, the H~2~S group and the DM+H~2~S group were administered 15 µmol/kg (i.p.) sodium hydrosulfide (NaHS, exogenous H~2~S donor; Sigma-Aldrich; Merck KGaA) every week for 8 consecutive weeks, whereas the control group and the DM group were administered normal saline only. At the age of 20 weeks, all rats were subjected to the following experiments.

### Intraperitoneal glucose tolerance test (IPGTT) and intraperitoneal insulin tolerance test (IPITT)

As previously reported ([@b12-mmr-22-03-1759]), IPITT and IPGTT were conducted at the age of 20 weeks. In terms of IPGTT, the rats were fasted overnight for 15 h, and were given 1.5 gr/kg glucose through an i.p. injection. Blood was collected from the tail vein for glucose measurements at 0, 10, 20, 30, 60, 90 and 120 min after glucose injection. As for IPITT, the rats received 2.5 U/kg insulin via i.p. injection, and then blood was drawn from the tail vein for glucose measurements at 0, 20, 30, 40, 60, 90 and 120 min after insulin administration.

### Intracardiac programmed electrical stimulus

As previously described, all groups were examined with electrophysiological characteristics via intracardiac programmed electrical stimulus ([@b13-mmr-22-03-1759]). Each animal was anesthetized with 2% isoflurane (Beijing Hongxin Technology) inhalation and fixed on a heated pad at the prone position to maintain 37°C body temperature. Surface electrocardiogram (ECG; B&W TEKSystems, Inc.) and intracardiac electrograms were recorded simultaneously. P wave duration and an indicator of intra-atrial conduction time were measured. An electrode catheter (1.1 F; Millar) was placed into the right atrium through the right jugular vein. A burst of electrical stimuli for 30 sec was used to test the inducibility of atrial arrhythmias. The burst test was conducted 3 times, and \>two incidents of AF observed (P wave disappeared and lasted \>2 sec) was judged as the onset of AF. LabChart Software 7.0 (ADInstruments) was used to record and analyze electrocardiogram data.

### Western blot analysis

As previously described ([@b14-mmr-22-03-1759]), expression levels of key proteins of the PI3K/Akt/endothelial nitric oxide synthase (eNOS) pathway in the atrial myocardium were examined with western blotting. The membranes were incubated with the following primary antibodies overnight at 4°C, anti-PI3K (1:2,000, cat. no. ab151549; Abcam), anti-Akt (1:2,000, cat. no. ab8805; Abcam), anti-phosphorylated (p)-Akt (1:500, cat. no. 9611; Cell Signaling Technology, Inc.), anti-p-eNOS (1:500, cat. no. ab184154; Abcam), anti-eNOS (1:500, cat. no. ab76198, Abcam) and anti-β-actin (1:5,000, cat. no. ab179467; Abcam). Following the primary incubation, membranes were incubated with rabbit anti-mouse (1:5,000, cat. no. ab150113; Abcam) or goat anti-rabbit HRP-conjugated secondary antibody (1:5,000, cat. no. ab150077; Abcam). Gel Imaging system (Bio-Rad Laboratories, Inc.) and ImageJ software (Version 1.8, National Institutes of Health) were used to image and analyze the western blotting bands.

### Reverse transcription-quantitative (RT-q)PCR

Total RNA from atrial myocardium samples was extracted using TRIzol (Takara Biotechnology Co., Ltd.). Total RNA (1,000 ng) was reverse transcribed into cDNA using the Prime-Script™ RT Reagent kit (Takara Biotechnology Co., Ltd.). Before performing the RT reaction, RNA (10 µl) was heated to 65°C for 5--10 min, and then quenched on ice. Then, the inversion system was prepared according to the instructions of the cDNA kit, the sample was placed at 25°C for 10 min and then incubated at 42°C for 1 h. Following which, the cDNA was denatured at 95°C and placed on ice.

RT-qPCR was performed using SYBR-Green (Takara Biotechnology Co., Ltd.) and normalized to β-actin expression. The fibroblast-to-myofibroblast transition marker α-smooth muscle actin, and atrial fibrosis markers, transforming growth factor (TGF)-β, collagen I, collagen III, were examined. A total of 30 cycles of PCR were performed: Denaturation at 95°C for 30 sec, annealing at 60°C for 45 sec, and extension at 72°C for 60 sec.

The primer sequences are listed as follows: Akt, 5′-AGCATGGAGTGTGTGGACAG-3′ (forward) and 5′-GATGATCCATGCGGGGCTT-3′ (reverse); eNOS, 5′-CGACTATCCTGTATGGCTCTGAG-3′ (forward) and 5′-GATCCCCATTGCCAAATGTGC-3′ (reverse); PI3K, 5′-GCTCTTTCCCCAGCTGAACT-3′ (forward) and 5′-ACACAGTGTCGCTGGTTTGA-3′ (reverse); β-actin: 5′-CATCCTGCGTCTGGACCGG-3′ (forward) and 5′-TAATGTCACGCACGATTTCC-3′ (reverse); TGF-β, 5′-CCCAGCATCTGCAAAGCTC-3′ (forward) and 5′-GTCAATGTACAGCTGCCGCA-3′ (reverse); collagen I, 5′-CATGTTCAGCTTTGTGGACCT-3′ (forward) and 5′-GCAGCTGACTTCAGGGATGT-3′ (reverse). The average expression of β-actin was used as an internal reference gene to normalize input cDNA. Relative gene expression was calculated via the threshold cycle value (CT) and the formula 2^−∆∆Cq^ ([@b15-mmr-22-03-1759]). All of the reactions were repeated at least twice, with at least 3 replicates for every sample.

### Masson\'s trichrome staining

According to a previous report ([@b16-mmr-22-03-1759]), Masson\'s trichrome staining was conducted to evaluate the extent of atrial fibrosis. After the rats were sacrificed, atrium samples were rapidly excised, rinsed with PBS, fixed in 4% paraformaldehyde at 4°C overnight, and embedded in paraffin. Then, 5-µm-thick sections at of the atrium were cut. Masson\'s trichrome kit (cat. no. HT15; Sigma-Aldrich; Merck KGaA) was used according to the manufacturer\'s instruction. ImageJ software (Version 1.8; National Institutes of Health) was used to evaluate the area of fibrosis. Each section was examined in 5 randomly-selected high-power fields (×400) and middle-power fields (×200) under a light microscope. Collagen volume fraction (CVF)=Collagen area (blue)/Total area ×100%.

### Cell culture

Cardiac fibroblasts (CFs) were harvested from the different groups, according to a previous report ([@b17-mmr-22-03-1759]). Following attachment to uncoated culture plates, all unattached or weakly attached cells were removed. Then, the attached fibroblasts were washed and grown in DMEM (Gibco; Thermo Fisher Scientific, Inc.) supplemented with 10% FBS (Gibco; Thermo Fisher Scientific, Inc.) at 37°C. CFs were plated on a 96-well plate at a density of 1×10^4^/well and cultured for 24 h.

### Cell proliferation assay

As previously described ([@b18-mmr-22-03-1759]), cell proliferation was examined using an MTT assay. Data values are expressed as fold-change compared with the control group.

### Cell migration

As previously described ([@b18-mmr-22-03-1759]), cell migration was examined with the real-time cell analyzer (RTCA) migration experiment. The CFs were seeded in RTCA Cim-16 plates in a serum-free DMEM medium with a cell density of at least 20,000/well. A chemoattractant of full growth medium (DMEM with 5--10% bovine serum albumin; cat. no. A1933; Sigma-Aldrich; Merck KGaA) was applied in the lower chamber. The RTCA device (xCELLigence RTCA; Roche Diagnostics) was used for measurements in a time-resolved manner ([@b18-mmr-22-03-1759]). The values are expressed as fold-change compared with the control group.

### Statistical analysis

GraphPad Prism 7.0 (GraphPad Software, Inc.) was used for statistical analysis. The AF incidence of four groups was compared with the Chi-square test. For comparison of normally distributed variables, one-way ANOVA and Tukey\'s post hoc test was performed. For comparison of AF duration, Kruskal-Wallis test and Dunn\'s multiple comparisons post hoc test were conducted. Data are presented as the mean ± SD. P\<0.05 was considered to indicate a statistically significant difference.

Results
=======

### DM model results

As demonstrated in [Fig. 1](#f1-mmr-22-03-1759){ref-type="fig"}, the FBG value was evaluated in the four groups at different points, including before the STZ injection, 1, 4 and 8 weeks after STZ injection. Before the injection, there was no difference in FBG among the four groups (P=0.5204), and the FBG varied between 90 and 110 mg/dl ([Fig. 1A](#f1-mmr-22-03-1759){ref-type="fig"}). However, 1 week after the STZ injection, the DM group and the DM+H~2~S group demonstrated a significant increase in the FBG level to 410.8±92.0 and 454.1±93.4 mg/dl, respectively, which were significantly higher than the control group and the H~2~S group (P\<0.0001). At the same time, there was no significant difference between the DM and DM+H~2~S group, and between the control group and the H~2~S group (both P\>0.05; [Fig. 1B](#f1-mmr-22-03-1759){ref-type="fig"}). The FBG level was examined 4 and 8 weeks after STZ injection, when NaHS had been administered. The results presented similar trends with the FBG level 1 week after STZ injection. The FBG of the DM group and the DM+H~2~S group was significantly higher than the control group and the H~2~S group (P\<0.0001). At the same time, there was no difference between the DM group and the DM+H~2~S group, the control group and the H~2~S group (both P\>0.05) ([Fig. 1C and D](#f1-mmr-22-03-1759){ref-type="fig"}).

IPITT and IPGTT ([Fig. 1E and F](#f1-mmr-22-03-1759){ref-type="fig"}) was performed to test insulin tolerance and glucose tolerance. The results were consistent with the FBG test, showing that the DM group and the DM+H~2~S group shared similar insulin and glucose tolerance, which was notably higher than the control group and the H~2~S group. However, there was no difference between the control group and the H~2~S group, and no difference DM+H~2~S group and the DM group. No significant side effects of NaHS were observed in the H~2~S group and the DM+H~2~S group.

### AF inducibility and persistence

As shown in [Fig. 2](#f2-mmr-22-03-1759){ref-type="fig"}, the intracardiac programmed electrical stimulus was applied to examine the AF inducibility of the four groups. [Fig. 2A](#f2-mmr-22-03-1759){ref-type="fig"} shows representative ECG figures of burst pacing and the subsequent heart rhythm. Compared with the other three groups, the DM group exhibited a much higher susceptibility of induced AF, with a significantly higher AF incidence (P=0.017). There was no statistical difference between the control group, the H~2~S group and the DM+H~2~S group in AF incidence ([Fig. 2B](#f2-mmr-22-03-1759){ref-type="fig"}). The AF duration of the DM group was significantly higher than the control group and the H~2~S group (P=0.005). Although the AF duration of the DM+H~2~S group was lower than the DM group, there was no statistical significance (P=0.085; [Fig. 2C](#f2-mmr-22-03-1759){ref-type="fig"}).

### Atrial fibrosis

Atrial remodeling of the four groups was also evaluated using Masson\'s trichrome staining ([Fig. 3](#f3-mmr-22-03-1759){ref-type="fig"}). More blue-stained collagen was observed in the DM group, indicating a more severe atrial fibrosis than the other groups, whereas the DM+H~2~S group suffered less fibrosis than the DM group ([Fig. 3A](#f3-mmr-22-03-1759){ref-type="fig"}). Fibrosis was quantified the with ImageJ software. The CVF value was calculated for the four groups, which indicated that the CVF of the DM group was significantly higher than the other groups (P\<0.0001). At the same time, there was no significant difference among the control group, the H~2~S group and the DM+H~2~S group (all P\>0.05; [Fig. 3B](#f3-mmr-22-03-1759){ref-type="fig"}). The key markers of fibrosis, including TGF-β and Collagen I, were also determined ([Fig. 3C and D](#f3-mmr-22-03-1759){ref-type="fig"}), which demonstrated that TGF-β and Collagen I of the DM group was significantly higher than the other groups (P\<0.0001). Fibrosis of the different groups was also examined at the cellular level by comparing the proliferation and migration of CFs. CF proliferation and migration of the DM group was significantly increased. In contrast, proliferation and migration of the DM+H~2~S group were lower than the DM group (P\<0.0001; [Fig. 3E and F](#f3-mmr-22-03-1759){ref-type="fig"}).

### PI3K/Akt/eNOS signaling pathway

As shown in [Fig. 4](#f4-mmr-22-03-1759){ref-type="fig"}, the classic PI3K/Akt/eNOS signaling pathway was evaluated in the four groups with RT-qPCR ([Fig. 4A-C](#f4-mmr-22-03-1759){ref-type="fig"}) and western blot analysis ([Fig. 4D-G](#f4-mmr-22-03-1759){ref-type="fig"}). The results demonstrated that this pathway was significantly downregulated in the DM group compared with the control group, which was reversed in the DM+H~2~S group. The expression levels of PI3K/Akt/eNOS were significantly higher in the DM+H~2~S group (P\<0.0001). Compared with the DM group, p-Akt/Akt and p-eNOS/eNOS ratios were significantly increased in the DM+H~2~S group ([Fig. 4F and G](#f4-mmr-22-03-1759){ref-type="fig"}).

Discussion
==========

H~2~S, an endogenous active molecule, has been demonstrated to be effective in organ protection for ischemia/reperfusion injury ([@b8-mmr-22-03-1759]). However, data concerning its effect on AF incidence, especially on DM-induced AF, is minimal. In the present study, SD rats were used as the research subject and a DM model was successfully established using STZ. It was demonstrated that DM rats had higher AF incidence and duration, which is associated with worse atrial fibrosis. It was also found that H~2~S could reduce AF incidence and mitigate the atrial fibrosis, which was achieved via the PI3K/Akt/eNOS pathway. Although there was no statistical difference between the DM group and DM+H~2~S group in AF duration, which could be attributed to the sample size, we propose that H~2~S could also shorten AF duration.

There are several ways to build DM animal models, including Zucker Diabetic Fatty rats, BioBreeding rats, LEW.1AR1-iddm rats, Goto-Kakizaki rats, chemically induced diabetic models, and non-obese diabetic mouse and Akita mouse models ([@b19-mmr-22-03-1759]). Hayami *et al* used STZ to damage pancreatic islet B cells and significantly increase blood glucose, and found that diabetic rats suffered severe inflammation and atrial fibrosis ([@b5-mmr-22-03-1759]). The present study used the same models as Hayami, and found that diabetic rats had not only worse atrial fibrosis, but also higher AF incidence and duration. Notably, the application of STZ for the DM model causes islet B cell injury and a shortage of insulin, which is similar to type 1 diabetes without insulin resistance. Saito *et al* ([@b4-mmr-22-03-1759]) used another diabetic rat model by administrating a high-fat diet and low-doses of STZ. In this way, the rats had the characteristics of insulin resistance and high blood glucose, which simulates type 2 diabetes.

Research on DM and AF has demonstrated that autonomic, electrical, electromechanical and structural remodeling, including oxidative stress, connexin remodeling and glycemic fluctuations, could be important reasons why patients with DM are at higher risk of AF ([@b20-mmr-22-03-1759]). Among all the mechanisms, oxidative stress and related structural remodeling lay the foundation of abnormal electrical activity ([@b6-mmr-22-03-1759]). Chang *et al* ([@b21-mmr-22-03-1759]) led a large-scale cohort study and found that metformin use was associated with a decreased risk of AF in patients with type 2 DM who were not using other anti-diabetic medication, most likely via attenuation of atrial cell tachycardia-induced myolysis and oxidative stress. Another study used the xanthine oxidase inhibitor allopurinol to prevent oxidative stress-mediated atrial remodeling in alloxan-induced DM rabbits ([@b22-mmr-22-03-1759]).

Activation of the PI3K/Akt/eNOS signaling pathway is associated with reduced reactive oxygen species production ([@b23-mmr-22-03-1759],[@b24-mmr-22-03-1759]). Chong *et al* ([@b25-mmr-22-03-1759]) found that resveratrol could decrease left atrial fibrosis and regulate variation in ion channels to reduce AF through the PI3K/Akt/eNOS signaling pathway. Hydrogen sulfide is closely associated with the PI3K/Akt pathway. Xiao *et al* ([@b26-mmr-22-03-1759]) investigated the effects of hydrogen sulfide on myocardial fibrosis and found that the protective effect of H~2~S against diabetes-induced myocardial fibrosis might be associated with the attenuation of autophagy via the upregulation of the PI3K/Akt1 signaling pathway. The present study found that H~2~S could significantly upregulate the PI3K/Akt/eNOS signaling pathway and reduce atrial fibrosis induced by DM. However, Xiao *et al* ([@b26-mmr-22-03-1759]) demonstrated decreased autophagy resulted from PI3K/Akt1 activation, which was not found in this study. Another study led by Liu *et al* ([@b27-mmr-22-03-1759]) also confirmed that H~2~S could ameliorate rat myocardial fibrosis induced by thyroxine, which may be associated with autophagy activated by upregulation of the PI3K/Akt signaling pathway and downregulation of miR-21, miR-34a and miR-214.

Several limitations of the present study must be noted. Firstly, despite the protective effect of H~2~S on DM-induced AF and atrial fibrosis, further mechanisms, such as inflammation, apoptosis or autophagy, were not investigated in this study due to limited time and funds. Secondly, this study only used the STZ-induced DM model, which is similar to type 1 DM, so conclusions are limited. Finally, electrical remodeling and cardiac structural function could be altered by DM status, which was also not investigated. However, these limitations can be resolved in further studies.

In conclusion, DM can lead to the structural remodeling of atrial fibrosis, increasing AF incidence and persistence. Administration of H~2~S does not affect glucose metabolism, but can significantly mitigate atrial fibrosis and reduce the incidence of AF, probably via the activation of the PI3K/Akt/eNOS pathway.
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![FBG level in the four groups at different time points. (A) FBG level before STZ injection. (B) FBG level at 1 week after STZ injection. (C) FBG level at 4 weeks after STZ injection. (D) FBG level at 8 weeks after STZ injection. (E) IPGTT results of the four groups. (F) IPITT results of the four groups. n=20 for each group. Data are presented as mean ± SD. \*\*\*\*P\<0.0001 vs. the control group; ^\#\#\#\#^P\<0.0001 vs. the DM group; ^++++^P\<0.0001 vs. the H~2~S group. FBG, fast blood glucose; STZ, streptozotocin; DM, diabetes mellitus; H~2~S, hydrogen sulfide; IPGTT, Intraperitoneal glucose tolerance test; IPITT, intraperitoneal insulin tolerance test.](MMR-22-03-1759-g00){#f1-mmr-22-03-1759}

![Intracardiac programmed electrical stimuli results. (A) Representative burst pacing electrocardiogram wave. (B) AF incidence in the four groups. (C) AF duration in the four groups. n=20 for each group. Data are presented as mean ± SD. \*\*P\<0.01 vs. the control group; ^\#^P\<0.05 vs. the DM group. DM, diabetes mellitus; AF, atrial fibrillation; H~2~S, hydrogen sulfide.](MMR-22-03-1759-g01){#f2-mmr-22-03-1759}

![Atrial structural remodeling of fibrosis. (A) Representative Masson\'s trichrome staining sections of the four groups. Scale bar, 100 µm. (B) CVF (%) in the four groups. (C) TGF-β mRNA expression in the four groups. (D) Collagen I mRNA expression in the four groups. (E) CF proliferation rate of the four groups. (F) CF migration rate of the four groups. n=20 for each group. Data are presented as mean ± SD. \*P\<0.05 and \*\*\*\*P\<0.0001 vs. the control group; ^\#\#^P\<0.01 and ^\#\#\#\#^P\<0.0001 vs. the DM group; ^++^P\<0.01 vs. the H~2~S group. Fold-change means the value compared with the control group. CF, cardiac fibroblasts; CVF, collagen volume fraction; TGF-β, tumor growth factor β; DM, diabetes mellitus; H~2~S, hydrogen sulfide.](MMR-22-03-1759-g02){#f3-mmr-22-03-1759}

![PI3k/Akt/eNOS pathway expression. (A) PI3K mRNA expression from atrium tissue normalized to β-actin. (B) Akt mRNA expression from atrium tissue normalized to β-actin. (C) eNOS mRNA expression from atrium tissue normalized to β-actin. (D) Representative western blotting bands of PI3K/Akt/eNOS pathway proteins. (E) PI3K protein expression level normalized to β-actin. (F) p-Akt/Akt protein level ratio. (G) p-eNOS/eNOS protein level ratio. n=20 for each group. Data are presented as mean ± SD. \*\*P\<0.01, \*\*\*P\<0.001 and \*\*\*\*P\<0.0001 vs. the control group; ^\#^P\<0.05, ^\#\#^P\<0.01, ^\#\#\#^P\<0.001 and ^\#\#\#\#^P\<0.0001 vs. the DM group. Fold-change indicates the value compared with the control group. p-, phosphorylated; eNOS, endothelial NOS; DM, diabetes mellitus; H~2~S, hydrogen sulfide; STZ, streptozotocin.](MMR-22-03-1759-g03){#f4-mmr-22-03-1759}

[^1]: Contributed equally
